{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:06:45Z","timestamp":1765728405819},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"9_Supplement_5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"DOI":"10.2146\/ajhp100149","type":"journal-article","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T19:44:09Z","timestamp":1271879049000},"page":"S17-S25","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacotherapeutic decision-making for patients with atrial fibrillation"],"prefix":"10.1093","volume":"67","author":[{"given":"James S.","family":"Kalus","sequence":"first","affiliation":[{"name":"Patient Care Services, Henry Ford Hospital, Detroit, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"4","key":"key\n\t\t\t\t2019041104104146800_b1-0670s17","first-page":"CD001925","article-title":"Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","author":"Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"key\n\t\t\t\t2019041104104146800_b2-0670s17","first-page":"CD006186","article-title":"Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks","author":"Aguilar","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"6 suppl","key":"key\n\t\t\t\t2019041104104146800_b3-0670s17","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041104104146800_b4-0670s17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b5-0670s17","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041104104146800_b6-0670s17","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jacc.2009.04.091","article-title":"Quality of care for atrial fibrillation among patients hospitalized for heart failure","volume":"54","author":"Piccini","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041104104146800_b7-0670s17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041104104146800_b8-0670s17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"ACTIVE Writing Group of the ACTIVE Investigators","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041104104146800_b9-0670s17","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"ACTIVE Investigators","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b10-0670s17","unstructured":"FDA drug safety communication: reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug. http:\/\/www.fda.gov\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm203888.htm#sa (accessed 2010 Mar 22)."},{"key":"key\n\t\t\t\t2019041104104146800_b11-0670s17","first-page":"279","article-title":"The arrhythmias","volume-title":"Pharmacotherapy: a pathophysiologic approach","author":"Sanoski","year":"2008","edition":"7th ed"},{"key":"key\n\t\t\t\t2019041104104146800_b12-0670s17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041104104146800_b13-0670s17","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","author":"Van Gelder","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b14-0670s17","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe1002301","article-title":"Rate control in atrial fibrillation","author":"Dorian","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b15-0670s17","first-page":"1699","article-title":"Digoxin","volume-title":"AHFS drug information 2010","author":"McEvoy","year":"2010"},{"key":"key\n\t\t\t\t2019041104104146800_b16-0670s17","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control with rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b17-0670s17","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b18-0670s17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation\u2014pharmacological intervention in atrial fibrillation (PIAF): a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041104104146800_b19-0670s17","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"key\n\t\t\t\t2019041104104146800_b20-0670s17","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041104104146800_b21-0670s17","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b22-0670s17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccl.2008.09.006","article-title":"Atrial fibrillation: goals of therapy and management strategies to achieve the goals","volume":"27","author":"Padanilam","year":"2009","journal-title":"Cardiol Clin"},{"key":"key\n\t\t\t\t2019041104104146800_b23-0670s17","first-page":"249","article-title":"Acute management of atrial fibrillation: part 1. Rate and rhythm control","volume":"66","author":"King","year":"2002","journal-title":"Am Fam Physician"},{"key":"key\n\t\t\t\t2019041104104146800_b24-0670s17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archinte.164.1.55","article-title":"National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation","volume":"164","author":"Fang","year":"2004","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041104104146800_b25-0670s17","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b26-0670s17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b27-0670s17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b28-0670s17","first-page":"1671","article-title":"Amiodarone hydrochloride","volume-title":"AHFS drug information 2010","author":"McEvoy","year":"2010"},{"key":"key\n\t\t\t\t2019041104104146800_b29-0670s17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4065\/84.3.234","article-title":"Benefits and risks of long-term amiodarone therapy for persistent atrial fibrillation: a meta-analysis","volume":"84","author":"Doyle","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019041104104146800_b30-0670s17","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041104104146800_b31-0670s17","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(00)03402-4","article-title":"Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial","volume":"356","author":"K\u00f8ber","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041104104146800_b32-0670s17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b33-0670s17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) sub-study","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041104104146800_b34-0670s17","volume-title":"Tikosyn package insert","year":"2006"},{"key":"key\n\t\t\t\t2019041104104146800_b35-0670s17","first-page":"1898","article-title":"Sotalol hydrochloride","volume-title":"AHFS drug information 2010","author":"McEvoy","year":"2010"},{"key":"key\n\t\t\t\t2019041104104146800_b36-0670s17","volume-title":"Betapace AF package insert","year":"2009"},{"key":"key\n\t\t\t\t2019041104104146800_b37-0670s17","unstructured":"U.S. Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. Multaq (dronedarone) briefing document. March18, 2009. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/CardiovascularandRenalDrugsAdvisoryCommittee\/UCM134981.pdf (accessed 2010 Feb 1)."},{"key":"key\n\t\t\t\t2019041104104146800_b38-0670s17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jacc.2009.04.085","article-title":"Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation","volume":"54","author":"Piccini","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041104104146800_b39-0670s17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b40-0670s17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b41-0670s17","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"K\u00f8ber","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041104104146800_b42-0670s17","volume-title":"Multaq package insert","year":"2009"},{"key":"key\n\t\t\t\t2019041104104146800_b43-0670s17","first-page":"1640","article-title":"Quinidine gluconate\/quinidine sulfate","volume-title":"AHFS drug information 2010","author":"McEvoy","year":"2010"},{"key":"key\n\t\t\t\t2019041104104146800_b44-0670s17","first-page":"1652","article-title":"Flecainide acetate","volume-title":"AHFS drug information 2010","author":"McEvoy","year":"2010"},{"key":"key\n\t\t\t\t2019041104104146800_b45-0670s17","first-page":"1660","article-title":"Propafenone hydrochloride","volume-title":"AHFS Drug Information 2010","author":"McEvoy","year":"2010"},{"key":"key\n\t\t\t\t2019041104104146800_b46-0670s17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.amjcard.2004.08.041","article-title":"Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation","volume":"94","author":"Kochiadakis","year":"2004","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041104104146800_b47-0670s17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1378\/chest.125.2.377","article-title":"Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses","volume":"125","author":"Kochiadakis","year":"2004","journal-title":"Chest"},{"issue":"4","key":"key\n\t\t\t\t2019041104104146800_b48-0670s17","first-page":"CD005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","author":"Lafuente-Lafuente","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2019041104104146800_b49-0670s17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","author":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","journal-title":"N Engl J Med"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/67\/9_Supplement_5\/S17\/28344005\/ajhp0s17.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:58:28Z","timestamp":1559044708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/67\/9_Supplement_5\/S17\/5129527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":49,"journal-issue":{"issue":"9_Supplement_5","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp100149","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,5,1]]},"published":{"date-parts":[[2010,5,1]]}}}